AAAAAA

   
Results: 1-11 |
Results: 11
HEALTH-RELATED QUALITY-OF-LIFE, ASSESSED BY THE EORTC QLQ-C30 (V1.0),IN PATIENTS WITH AGGRESSIVE LYMPHOMAS TREATED WITH CHOP OR MACOP-B INA MULTI CENTER RANDOMIZED TRIAL BY THE NORDIC LYMPHOMA GROUP
Authors: JERKEMAN M KASSA S KVALOY S CAVALLINSTAHL E
Citation: M. Jerkeman et al., HEALTH-RELATED QUALITY-OF-LIFE, ASSESSED BY THE EORTC QLQ-C30 (V1.0),IN PATIENTS WITH AGGRESSIVE LYMPHOMAS TREATED WITH CHOP OR MACOP-B INA MULTI CENTER RANDOMIZED TRIAL BY THE NORDIC LYMPHOMA GROUP, Annals of oncology, 9, 1998, pp. 519-519
COMBINATION CHEMOTHERAPY WITH MITOGUAZON, IFOSFAMIDE, MTX, ETOPOSIDE (MIME) AND G-CSF CAN EFFICIENTLY MOBILIZE PBPC IN PATIENTS WITH HODGKINS AND NON-HODGKINS-LYMPHOMA
Authors: AURLIEN E HOLTE H PHARO A KVALOY S JAKOBSEN E SMELAND EB KVALHEIM G
Citation: E. Aurlien et al., COMBINATION CHEMOTHERAPY WITH MITOGUAZON, IFOSFAMIDE, MTX, ETOPOSIDE (MIME) AND G-CSF CAN EFFICIENTLY MOBILIZE PBPC IN PATIENTS WITH HODGKINS AND NON-HODGKINS-LYMPHOMA, Bone marrow transplantation, 21(9), 1998, pp. 873-878
HODGKINS-DISEASE IN A NATIONAL AND HOSPITAL POPULATION - TRENDS OVER 20 YEARS
Authors: ABRAHAMSEN AF EGELAND T HANSEN S LANGHOLM R HOLTE H KVALOY S
Citation: Af. Abrahamsen et al., HODGKINS-DISEASE IN A NATIONAL AND HOSPITAL POPULATION - TRENDS OVER 20 YEARS, European journal of cancer, 33(14), 1997, pp. 2380-2383
BONE-MARROW MR-IMAGING BEFORE AND AFTER AUTOLOGOUS MARROW TRANSPLANTATION IN LYMPHOMA PATIENTS WITHOUT KNOWN BONE-MARROW INVOLVEMENT
Authors: LIEN HH BLOMLIE V BLYSTAD AK HOLTE H LANGHOLM R KVALOY S
Citation: Hh. Lien et al., BONE-MARROW MR-IMAGING BEFORE AND AFTER AUTOLOGOUS MARROW TRANSPLANTATION IN LYMPHOMA PATIENTS WITHOUT KNOWN BONE-MARROW INVOLVEMENT, Acta radiologica, 38(5), 1997, pp. 896-902
A RANDOMIZED COMPARISON OF LIPOSOMAL VERSUS CONVENTIONAL AMPHOTERICIN-B FOR THE TREATMENT OF PYREXIA OF UNKNOWN ORIGIN IN NEUTROPENIC PATIENTS
Authors: PRENTICE HG HANN IM HERBRECHT R AOUN M KVALOY S CATOVSKY D PINKERTON CR SCHEY SA JACOBS F OAKHILL A STEVENS RF DARBYSHIRE PJ GIBSON BES
Citation: Hg. Prentice et al., A RANDOMIZED COMPARISON OF LIPOSOMAL VERSUS CONVENTIONAL AMPHOTERICIN-B FOR THE TREATMENT OF PYREXIA OF UNKNOWN ORIGIN IN NEUTROPENIC PATIENTS, British Journal of Haematology, 98(3), 1997, pp. 711-718
CLINICAL STAGE-I AND STAGE-II HODGKINS-DISEASE - LONG-TERM RESULTS OFTHERAPY WITHOUT LAPAROTOMY - EXPERIENCE AT ONE INSTITUTION
Authors: ABRAHAMSEN AF HANNISDAL E NOME O HOLTE H HAGER B LANGHOLM R KVALOY S
Citation: Af. Abrahamsen et al., CLINICAL STAGE-I AND STAGE-II HODGKINS-DISEASE - LONG-TERM RESULTS OFTHERAPY WITHOUT LAPAROTOMY - EXPERIENCE AT ONE INSTITUTION, Annals of oncology, 7(2), 1996, pp. 145-150
PROGNOSTIC VARIABLES AND RESULTS OF SALVAGE TREATMENT IN HODGKINS-DISEASE
Authors: ABRAHAMSEN AF HANNISDAL E NOME O ELGJO RF HOLTE H HAGER B LANGHOLM R KVALOY S
Citation: Af. Abrahamsen et al., PROGNOSTIC VARIABLES AND RESULTS OF SALVAGE TREATMENT IN HODGKINS-DISEASE, Acta oncologica, 35, 1996, pp. 67-72
ACTIVATION OF COAGULATION AND DEEP-VEIN THROMBOSIS AFTER BONE-MARROW HARVESTING AND INSERTION OF A HICKMAN-CATHETER IN ABMT PATIENTS WITH MALIGNANT-LYMPHOMA
Authors: SLETNES KE HOLTE H HALVORSEN S JAKOBSEN E WISLOFF F KVALOY S
Citation: Ke. Sletnes et al., ACTIVATION OF COAGULATION AND DEEP-VEIN THROMBOSIS AFTER BONE-MARROW HARVESTING AND INSERTION OF A HICKMAN-CATHETER IN ABMT PATIENTS WITH MALIGNANT-LYMPHOMA, Bone marrow transplantation, 17(4), 1996, pp. 577-581
MAGNETIC-RESONANCE-IMAGING AND GA-67 SCAN IN MEDIASTINAL MALIGNANT-LYMPHOMA - A PROSPECTIVE PILOT-STUDY
Authors: ABRAHAMSEN AF LIEN HH AAS M WINDEREN M HAGER B KVALOY S ELGJO RF NOME O
Citation: Af. Abrahamsen et al., MAGNETIC-RESONANCE-IMAGING AND GA-67 SCAN IN MEDIASTINAL MALIGNANT-LYMPHOMA - A PROSPECTIVE PILOT-STUDY, Annals of oncology, 5(5), 1994, pp. 433-436
FOLLOW-UP OF BREAST-CANCER PATIENTS STAGE I-II - A BASE-LINE STRATEGY
Authors: HANNISDAL E GUNDERSEN S KVALOY S LINDEGAARD MW AAS M FINNANGER AM JORGENSEN OG THEODORSEN L HOST H
Citation: E. Hannisdal et al., FOLLOW-UP OF BREAST-CANCER PATIENTS STAGE I-II - A BASE-LINE STRATEGY, European journal of cancer, 29A(7), 1993, pp. 992-997
HIGH-LEVELS OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) IN PLASMA FROM MANY PATIENTS WITH SOLID TUMORS CONTRAST WITH FINDINGS IN LYMPHOMA PATIENTS
Authors: IVERSEN N LINDAHL AK KVALOY S ABILDGAARD U
Citation: N. Iversen et al., HIGH-LEVELS OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) IN PLASMA FROM MANY PATIENTS WITH SOLID TUMORS CONTRAST WITH FINDINGS IN LYMPHOMA PATIENTS, Thrombosis and haemostasis, 69(6), 1993, pp. 602-602
Risultati: 1-11 |